Key facts
- This page summarizes Bryan K. Gathagan's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2025, 17:09.
Bryan K. Gathagan - 12 Jun 2025 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)
- Reporting relationship
- Director
- Issuer ticker
- ICCC
- Reported as of
- 12 Jun 2025
- Net transaction value
- +$6,320
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2025, 17:09:47 UTC
- Prior SEC filing
- 14 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael F. Brigham
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bryan K. Gathagan filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 12 Jun 2025.
Change
- Previous filing in this sequence was filed on 14 Apr 2026.
- Current net transaction value: +$6,320.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001981919
Primary reporting owner
Gathagan Bryan K.
- Relationship
- Director
- Address
- C/O IMMUCELL CORPORATION , 56, EVERGREEN DRIVE, PORTLAND
- Signature
- /s/ Michael F. Brigham
- Signature date
- 12 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ICCC
transaction
Common stock $0.10 per value per share
Purchase
- Transaction value
- $6,320
- Shares
- +1,000
- Change %
- Price
- $6.32
- Shares after
- 1,000
- Date
- 12 Jun 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.